Case Report
Copyright ©The Author(s) 2024.
World J Clin Cases. May 26, 2024; 12(15): 2614-2620
Published online May 26, 2024. doi: 10.12998/wjcc.v12.i15.2614
Table 1 The laboratory result of the patient before treatment
Laboratory result
Normal
WBC (109/L) 2.22(3.4-9.5)
HB (g/L) 80(115-150)
Platelet (109/L) 31(125-350)
PT(s) 13.5(9.7-13.5)
Dimer (mg/L) 4.36(0-0.55)
ALT (u/L)23(9-50)
TB (umol/L)20.89(3-20)
CK (u/L)30(20-180)
CK-MB (u/L)20(0-30)
Cr (umol/L)67(40-80)
CA199 (kU/L)6.20(0-35)
CEA (ug/L)1.90(0-5)
AFP (ug/L)12.48(0-9)
CA125 (ug/L)101.10(0-35)
CRP (mg/L) 9.50(0-10)
Triglyceride (mmol/L)0.60(0-1.7)
Cholesterol (mmol/L)2.87(2.86-5.98)
Amylase (U/L)201(35-135)
Lipase (U/L)106(0-190)
Glucose (mmol/L)5.413.0-6.1
HbsAgNegativeNegative
HIV AbNegativeNegative
Sp AbNegativeNegative
ANANegativeNegative
Hc AbNegativeNegative
WBC: White blood cell; HB: Hemoglobin; TB: Total bilirubin; CK: Creatine kinase; ALT: Alanine aminotransferase; Cr: Creatinine; CEA: Carcinoembryonic antigen; AFP: Alpha-fetoprotein; CA: Carbohydrate antigen; CRP: C-reactive protein; PT: Prothrombin time; HbsAg: Hepatitis B surface antigen; Hc Ab: Hepatitis C antibody; HIV Ab: Human immunodefciency virus antibody; Sp Ab: Syphilis antibody; ANA: Anti-nuclear anti-bodies.